The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized, open-label, non-inferiority, phase 3 study of subcutaneous (SC) versus intravenous (IV) daratumumab (DARA) administration in patients with relapsed or refractory multiple myeloma (RRMM): COLUMBA.
 
Saad Zafar Usmani
Consulting or Advisory Role - Amgen; Celgene; Janssen Oncology
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics; Sanofi
 
Maria-Victoria Mateos
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda
 
Nizar J. Bahlis
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen
Research Funding - Celgene; Janssen
 
Sebastian Grosicki
No Relationships to Disclose
 
Andrew Spencer
Consulting or Advisory Role - Janssen
Speakers' Bureau - Janssen
Research Funding - Janssen
 
Rajesh Bandekar
Employment - Janssen
 
Tara J. Masterson
Employment - Janssen
 
Pamela L. Clemens
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Christoph Johann Heuck
Employment - Janssen
 
Ming Qi
Employment - Janssen
 
Hareth Nahi
No Relationships to Disclose